Synergistic antibacterial activity of clavulanic acid and amoxicillin against beta-lactamase-producing strains of Haemophilus ducreyi.

Antimicrobial Agents and Chemotherapy
Y C GirouardW L Albritton

Abstract

The susceptibility of 47 strains of Haemophilus ducreyi to amoxicillin, clavulanic acid, and the combination of both drugs was determined by agar dilution susceptibility testing. A synergistic antibacterial activity of the combination was found for beta-lactamase-producing strains.

References

Apr 1, 1978·Antimicrobial Agents and Chemotherapy·G W HammondA R Ronald
Nov 1, 1978·Antimicrobial Agents and Chemotherapy·H C Neu, K P Fu
Feb 1, 1979·Antimicrobial Agents and Chemotherapy·J L BruntonW L Albritton
May 1, 1977·Antimicrobial Agents and Chemotherapy·C Reading, M Cole
Jun 1, 1976·The Journal of Antibiotics·A G BrownG N Rolinson
Apr 1, 1975·International Journal of Dermatology·A Gaisin, C L Heaton
Apr 1, 1972·Antimicrobial Agents and Chemotherapy·C H O'CallaghanA H Shingler
May 1, 1972·The Journal of Urology·J L Marmar
Nov 1, 1969·Archives of Dermatology·R E KerberK R Gilbert
May 1, 1980·Antimicrobial Agents and Chemotherapy·I W MacLeanW L Albritton
Jun 1, 1980·Antimicrobial Agents and Chemotherapy·M MatsuuraS Mitsuhashi

❮ Previous
Next ❯

Citations

Jun 1, 1986·Antimicrobial Agents and Chemotherapy·B M JonesB I Duerden
Jun 1, 1985·Drug Intelligence & Clinical Pharmacy·B R Smith, J L LeFrock
May 1, 1985·Infection Control : IC·J A Daly
Aug 30, 2019·Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·Juan Pablo Loyola-RodriguezOscar Sanchez-Adame

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.